Drawing for REVIVAL

USPTO serial 79297218

REVIVAL

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
CHUNG, DIANA ALANA
Law office
TMO LAW OFFICE 129 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with REVIVAL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Krista Weber Powell

Krista Weber Powell Traskbritt, P.C.230 South 500 East, #300Salt Lake City, UT 84102UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and medical preparations for the treatment of infectious diseases, inflammatory diseases, kidney diseases, deficiency diseases; diagnostic preparations for medical use; enzyme preparations for medical use; medicines for human use for the treatment of infectious diseases; inflammatory diseases, kidney diseases, deficiency diseases; pharmaceutical drugs for the treatment of inflammatory diseases, kidney diseases, deficiency diseases, infectious diseases; pharmaceutical preparations for the treatment of kidney diseases and disordersACTIVE—
042Scientific and technological services, namely, research and design in the field of computer datacenter architecture; scientific, technological and industrial research, namely scientific research, analysis, and reporting in the field of medicine and pharmaceutical preparations for the treatment of infectious diseases, inflammatory diseases, kidney diseases, deficiency diseases, autoimmune diseases; industrial analysis and industrial research in the field of medicine and drug development for treating infectious diseases, inflammatory diseases, kidney diseases, deficiency diseases; product development of technologies, diagnostics, pharmaceuticals, biotechnological research related to enzymatic synthesis; testing, authentication and quality control of pharmaceuticals for others; medical and pharmaceutical research services; provision of medical and scientific research information in the field of pharmaceutical products and clinical trials; drug research services; research and development services for the pharmaceutical and biotechnology industry; pharmaceutical drug development services; pharmaceutical product testing; development of pharmaceutical preparations and drugs; consultancy in the field of pharmaceutical research; clinical and medical research; scientific research for medical purposes, namely conducting clinical trials for others; conducting clinical trials for pharmaceutical products for othersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 12, 2023FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 20, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 20, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 20, 2022MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 20, 2022MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 20, 2022ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Apr 24, 2022OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Apr 7, 2022GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Apr 7, 2022GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 7, 2022CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 6, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 6, 2022OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jan 10, 2022DOCKASSIGNED TO EXAMINER—
May 27, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 27, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 27, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 20, 2020RFNTREFUSAL PROCESSED BY IB—
Nov 29, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 29, 2020RFRRREFUSAL PROCESSED BY MPU—
Nov 11, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 10, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 10, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 6, 2020DOCKASSIGNED TO EXAMINER—
Nov 6, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 5, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance